Busey Bank’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$507K Sell
1,731
-10
-0.6% -$3.29K 0.01% 244
2025
Q4
$610K Buy
1,741
+10
+0.6% +$3.38K 0.02% 227
2025
Q3
$559K Buy
1,731
+142
+9% +$44.2K 0.02% 234
2025
Q2
$618K Buy
1,589
+1
+0.1% +$402 0.02% 220
2025
Q1
$691K Sell
1,588
-19
-1% -$7.63K 0.02% 204
2024
Q4
$593K Sell
1,607
-62
-4% -$25.9K 0.02% 217
2024
Q3
$868K Buy
1,669
+6
+0.4% +$3.21K 0.03% 184
2024
Q2
$901K Sell
1,663
-38
-2% -$20.1K 0.03% 180
2024
Q1
$882K Buy
1,701
+25
+1% +$12.4K 0.03% 181
2023
Q4
$790K Sell
1,676
-163
-9% -$75.4K 0.03% 184
2023
Q3
$801K Sell
1,839
-184
-9% -$83.5K 0.03% 177
2023
Q2
$899K Sell
2,023
-1
-0% -$461 0.04% 183
2023
Q1
$931K Sell
2,024
-36
-2% -$17.1K 0.04% 185
2022
Q4
$1.06M Sell
2,060
-9
-0.4% -$4.57K 0.05% 174
2022
Q3
$940K Sell
2,069
-41
-2% -$19.6K 0.05% 180
2022
Q2
$1.02M Sell
2,110
-143
-6% -$70.7K 0.05% 181
2022
Q1
$1.11M Sell
2,253
-50
-2% -$22.9K 0.04% 191
2021
Q4
$1.07M Sell
2,303
-8
-0.3% -$3.37K 0.04% 190
2021
Q3
$862K Sell
2,311
-8
-0.3% -$3.04K 0.03% 203
2021
Q2
$886K Sell
2,319
-156
-6% -$59.6K 0.04% 183
2021
Q1
$889K Sell
2,475
-66
-3% -$21.2K 0.04% 181
2020
Q4
$816K Sell
2,541
-261
-9% -$80.1K 0.05% 179
2020
Q3
$752K Sell
2,802
-25
-0.9% -$6.73K 0.05% 184
2020
Q2
$744K Sell
2,827
-152
-5% -$40.6K 0.05% 179
2020
Q1
$676K Sell
2,979
-48
-2% -$13.1K 0.05% 186
2019
Q4
$915K Buy
3,027
+654
+28% +$180K 0.06% 189
2019
Q3
$570K Buy
2,373
+1,321
+126% +$362K 0.04% 211
2019
Q2
$297K Sell
1,052
-33
-3% -$9.01K 0.03% 185
2019
Q1
$311K Buy
1,085
+67
+7% +$19.4K 0.03% 179
2018
Q4
$268K Hold
1,018
0.03% 180
2018
Q3
$279K Sell
1,018
-18
-2% -$4.67K 0.03% 176
2018
Q2
$247K Sell
1,036
-214
-17% -$49.6K 0.02% 184
2018
Q1
$275K Buy
+1,250
New +$294K 0.03% 178
2017
Q4
Sell
-1,200
Closed -$228K 196
2017
Q3
$228K Buy
+1,200
New +$228K 0.03% 172

Other funds holding ELV

Busey Bank's ELV Position: Q1 2026 in Review

Busey Bank reduced its Elevance Health (ELV) stake by 0.57% in Q1 2026, selling an estimated $3.29K and leaving 1,731 shares worth $507K. The position accounts for 0.01% of the portfolio, ranked #244.

Busey Bank first reported a position in ELV in Q3 2017 and has held it in 34 quarters since. The position peaked at $1.11M in Q1 2022. 1,464 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Busey Bank held 1,731 shares of Elevance Health worth $507K as of Q1 2026.
  • Busey Bank sold 10 Elevance Health shares in Q1 2026, an estimated $3.29K.
  • Elevance Health made up 0.01% of Busey Bank's portfolio in Q1 2026, its #244 holding.
  • Busey Bank first reported a position in Elevance Health in Q3 2017 and has held it in 34 quarters since.
  • Busey Bank's Elevance Health position peaked at $1.11M in Q1 2022.
  • 1,464 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Busey Bank's 13F filing for Q1 2026, filed 28 Apr 2026.